Election Day is coming — are you registered to vote?
119th Congress
Independent · Nonpartisan · Reader-supported
HOUSEH.Res. 342· 119th Congress

Recognize DES Drug Harm History

Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.

Sponsor
James McGovern (D-MA)
Introduced
Apr 21, 2025
Last Action
Apr 21, 2025
Passage
28%
Introduced
Apr 21, 2025
2
Committee
3
Floor Vote
4
Both Chambers
5
Enacted
01 — The Text

What.

  • House resolution documenting the history and harmful effects of diethylstilbestrol (DES), a synthetic hormone prescribed to pregnant women mid-20th century.
  • Acknowledges widespread health damage to exposed mothers and multiple generations of children born to those mothers.
  • Detailed summary not yet available; full legislative text will clarify specific provisions or commemorative language.
02 — The Stakes

So what?

  • Affects DES-exposed individuals and their descendants—estimated millions—who experienced increased cancer, reproductive issues, and other conditions.
  • Recognition matters for affected families seeking acknowledgment of harm and potential catalyst for future compensation or medical support discussions.
  • No direct federal funding or new programs apparent yet; real impact depends on bill's final language and whether it leads to broader action.
03 — The Path

Now what?

  • Bill introduced April 21, 2025; referred to House Energy and Commerce Committee. Typical resolution path: committee review, then floor vote if advanced.
  • No cosponsors yet signals limited initial momentum; passage would be symbolic unless paired with separate legislation for funding or services.
  • Track progress at Congress.gov or contact your House representative to support or oppose recognition of DES harm.
Legislative History

Actions.

  • Apr 21, 2025Referred to the House Committee on Energy and Commerce.
  • Apr 21, 2025Submitted in House
  • Apr 21, 2025Submitted in House